(Q54239486)

26 May 2018

title

Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. (English)

1 reference

26 May 2018

1 reference

Bergman PJ

1

1 reference

26 May 2018

Camps-Palau MA

2

1 reference

26 May 2018

McKnight JA

3

1 reference

26 May 2018

Leibman NF

4

1 reference

26 May 2018

Craft DM

5

1 reference

26 May 2018

Leung C

6

1 reference

26 May 2018

Liao J

7

1 reference

26 May 2018

Riviere I

8

1 reference

26 May 2018

Sadelain M

9

1 reference

26 May 2018

Hohenhaus AE

10

1 reference

26 May 2018

Gregor P

11

1 reference

26 May 2018

Houghton AN

12

1 reference

26 May 2018

Perales MA

13

1 reference

26 May 2018

Wolchok JD

14

1 reference

26 May 2018

language of work or name

English

0 references

publication date

24 August 2005

1 reference

26 May 2018

published in

Vaccine

1 reference

26 May 2018

volume

24

1 reference

26 May 2018

page(s)

4582-4585

1 reference

26 May 2018

issue

21

1 reference

26 May 2018

Canine oral melanoma: comparison of surgery versus surgery plus Corynebacterium parvum

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

0-7-21 radiation therapy for the treatment of canine oral melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Prognosis after Surgical Excision of Canine Melanomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Retrospective study of 338 canine oral melanomas with clinical, histologic, and immunohistochemical review of 129 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Medical treatment of metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Vaccines for melanoma: translating basic immunology into new therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989-2000)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

A retrospective analysis of 140 dogs with oral melanoma treated with external beam radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Preclinical development of human granulocyte-macrophage colony-stimulating factor-transfected melanoma cell vaccine using established canine cell lines and normal dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Development of human granulocyte-macrophage colony-stimulating factor-transfected tumor cell vaccines for the treatment of spontaneous canine cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

A phase I study using direct combination DNA injections for the immunotherapy of metastatic melanoma. University of Colorado Cancer Center Clinical Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Enhancing antimelanoma immune responses through apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Vaccine development against HIV-1: current perspectives and future directions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Tumor immunity and autoimmunity induced by immunization with homologous DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Vaccines and other adjuvant therapies for melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

Strategies to overcome immune ignorance and tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.027

10.1016/J.VACCINE.2005.08.027

7 January 2021

Identifiers

DOI

1 reference

26 May 2018

PubMed ID

16188351

1 reference

26 May 2018